Business Wire Feed
Rockwell Medical to Release First Quarter 2026 Results on Thursday, May 7, 2026
WIXOM, Mich.--(BUSINESS WIRE)--$RMTI #EndStageKidneyDisease--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its more...
Latigo Biotherapeutics Appoints Sara M. Bonstein to its Board of Directors and as Audit Committee Chair
Experienced chief financial officer brings deep financial and strategic leadership to Latigo’s board of directors Appointment supports continued operational growthTHOUSAND OAKS, Calif.--(BUSINESS WIRE)--Latigo Biotherapeutics, Inc. (Latigo), a clinical-stage biopharmaceutical company committed to developing innovative non-opioid more...
Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced the Company more...
KalVista Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference
FRAMINGHAM, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today announced that the Company will participate in a fireside chat at the 25th Annual Needham Virtual Healthcare Conference, April 15, 2026, at 10:15 a.m. more...
VION Biosciences Closes Acquisition of CTL, Strengthening Functional Immune Monitoring Capabilities
CTL adds analyzers, software, consumables, and services at a workflow-critical measurement layer across translational and clinical researchSHAKER HEIGHTS, Ohio--(BUSINESS WIRE)--VION Biosciences ("VION"), a life sciences company building differentiated capabilities across research, diagnostics, and drug development more...
Americhem Announces Expansion of Global Healthcare Footprint with New China Investment at Chinaplas 2026
CUYAHOGA FALLS, Ohio & SUZHOU, China--(BUSINESS WIRE)--Americhem, a global leader in polymer solutions, today announced an expansion of its healthcare capabilities with a new clean compounding facility in Suzhou, China, alongside the introduction of advanced more...
Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™ Advanced Update
Increased cutting speed of 25,000 cuts per minute1 is designed to minimize retinal traction,2 increase vitreous flow,1 and reduce infusion pressure fluctuations when used with Adaptive Fluidics.3* Bi-Blade+ provides an average flow rate increase of more...
Compass Pathways to Attend Needham Virtual Healthcare Conference on April 14, 2026
LONDON & NEW YORK--(BUSINESS WIRE)--$CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the Needham Virtual Healthcare Conference more...
Flashfood and Kroger Expand Partnership Across Kroger’s Entire Mid-Atlantic Division
The rollout adds Flashfood to 100+ Kroger stores in Virginia, West Virginia, Ohio and KentuckyRICHMOND, Va.--(BUSINESS WIRE)--Flashfood, the surplus grocery platform trusted by North America’s leading grocery retailers, is now available at all 100+ Kroger more...
Hemispherian Initiates Phase 1/2a Clinical Trial of GLIX1 in Glioblastoma
First-in-class TET2 activator targets DNA damage response in GBM and other cancers Strong preclinical efficacy, brain penetration, and safety profile support clinical advancement Study led by world-leading glioblastoma investigators, including Dr. Roger StuppOSLO, Norway--(BUSINESS WIRE)--#Biotech--Hemispherian more...
Innate Pharma to Present at the AACR 2026 Oncology Industry Partnering Event
MARSEILLE, France--(BUSINESS WIRE)--#AACR--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company"), announced today that Yannis Morel, Chief Operating Officer, will present at the AACR Oncology Industry Partnering Event: From Cancer more...
Small-Town Hospital in Germany Emerges as Regional Radiosurgery Leader with ZAP-X, Celebrating 5 Years of Clinical Excellence
St. Bonifatius Hospital in Lingen approaches 1,000 patients treated and defies expectations – delivering world-class stereotactic radiosurgery at volumes more than 5X higher than typical for its populationSAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a more...
NeoGenomics to Report First Quarter 2026 Financial Results on April 28, 2026
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will report its first quarter 2026 financial results after the close of the more...
FDA Grants De Novo Classification to neuropacs™, a First-in-Class AI-Based MRI Diagnostic Aid for Parkinsonian Syndromes
Multicenter Clinical Evidence Supports Use of neuropacs™ to Assist Clinicians in Differentiating Parkinsonian Syndromes, Strengthening Commercial MomentumGAINESVILLE, Fla.--(BUSINESS WIRE)--Neuropacs™ Corp., an innovator in AI-enabled neurological imaging, today announced that the U.S. Food and Drug Administration more...
Bruker Invests in Photothermal AFM-IR to Advance Semiconductor Research
Dimension IconIR to Support Critical Materials Characterization for Next-Generation Semiconductor Devices BILLERICA, Mass.--(BUSINESS WIRE)--$BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced accelerated development of its photothermal AFM-IR spectroscopy capabilities to address research challenges facing the semiconductor more...
CatalYm Doses First Patient in Phase 2b Trial Evaluating Visugromab in Combination with Chemoimmunotherapy as Second-Line Treatment in Unresectable/Metastatic Hepatocellular Carcinoma
Study targets patients with unresectable or metastatic hepatocellular carcinoma who have progressed following first-line anti-PD-(L)1-based therapy Initiation of the third Phase 2b study of visugromab, expanding development into hepatocellular carcinoma following first and second-line NSCLC more...
Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation
U.S. IDE Enrollment follows groundbreaking 96% procedural success at 12 months in European feasibility studyHAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation (nsPFA™) energy, today announced more...
Bausch + Lomb Launches Preloaded enVista Envy™ Full Range of Vision Intraocular Lenses in Europe
enVista Envy is the first diffractive premium IOL from Bausch + Lomb available in Europe Offers a continuous range of vision with excellent dysphotopsia tolerance EyeGility™ delivery system contributes to smooth, efficient lens delivery VAUGHAN, more...
AIRNA Announces First Patient Dosed in Phase 1 Trial of AIR-001, Potential Best-in-Class RNA-Editing Therapy for Alpha-1 Antitrypsin Deficiency (AATD)
- U.S. Food and Drug Administration grants Orphan Drug Designation to AIR-001 for treatment of AATD - - Clearance received from regulatory authorities in multiple countries to initiate Phase 1 clinical study - - Global more...
Agiliti Introduces Capillaire™ — Low-Profile Alternating Pressure Overlay Clinically Proven to Prevent Perioperative Pressure Injuries
One-of-a-kind technology enhances care for patients across surgical, perioperative and emergency care environmentsMINNEAPOLIS--(BUSINESS WIRE)--Agiliti, a leading manufacturer and provider of medical device solutions to the U.S. healthcare industry, today announced the launch of Capillaire™, a more...
Alzheon Advances Industry-Leading Portfolio of Oral Anti-Amyloid Aggregation Inhibitors with First Subject Dosed in Phase 1 of ALZ-507, Highlighting Potential for Once-Daily Administration, Improved Safety and Efficacy, and APOE4 Corrector Mechanism
ALZ-507 Designed as Well-Differentiated Oral Candidate Targeting Soluble Amyloid Oligomer Pathology, with Additional Mechanism of Action as APOE4 Corrector ALZ-507 IND Program Demonstrated Favorable Nonclinical Safety and Pharmacokinetic Profile that Supports Once-Daily Dosing ALZ-507 Broadens more...
Affinia Therapeutics Receives Approval from Health Canada to Initiate the UPBEAT© Trial, a Phase 1/2 Clinical Trial to Investigate AFTX-201 as a Treatment for BAG3-Associated Dilated Cardiomyopathy (DCM)
An investigational medicine that addresses the genetic root cause of BAG3 DCM, AFTX-201 is being evaluated as a treatment for BAG3 DCM in the UPBEAT trial in the U.S. and Canada AFTX-201 is designed using more...
Glaukos to Present Multiple Scientific Abstracts at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, announced today that its technologies will be more...
Bausch + Lomb Announces New Scientific Data, Educational Events at the American Society of Cataract and Refractive Surgery Annual Meeting
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the presentation of new scientific data and events taking place more...
MedTech Innovator Radar Forum April 7-9 Levels Up MedTech Industry’s Most Rigorous Evaluation Platform and Leading Accelerator Program
LOS ANGELES--(BUSINESS WIRE)--#innovation--MedTech Innovator (MTI), the world’s largest and most impactful accelerator for early to mid-stage medical technology startups, today announced the evolution of its long-standing multi-city Road Tour pitch events into a single consolidated more...